Cagrilintide for Sale — Research-Grade, Third-Party Tested
Looking to buy Cagrilintide? MyGLP1Store offers Cagrilintide for sale as a third-party lab-tested research peptide sourced direct from the manufacturer, with purity documented per lot and same-day U.S. shipping. Veteran-owned and trusted by researchers (Trustpilot 4.8). For laboratory research use only.
Cagrilintide (CAGRI) – 5mg Lyophilized Research Peptide
Cagrilintide (research code AM833), listed in research catalogs as CAGRI, is a long-acting amylin analog studied in metabolic research models for its role in appetite regulation, satiety signaling, and energy balance. Amylin is a peptide hormone co-secreted with insulin; long-acting analogs such as cagrilintide are widely investigated in obesity and metabolic research, frequently alongside GLP-1 receptor agonists.
What Is Cagrilintide Used for in Research?
In laboratory settings, Cagrilintide (CAGRI) is explored for amylin-receptor signaling, food-intake regulation, post-meal glucose response, and combination models. One of the most studied combinations pairs Cagrilintide with Semaglutide — together referred to as CagriSema — to investigate complementary appetite and metabolic pathways. For a deeper overview of how amylin analogs are studied alongside incretin compounds, see our guide to GLP-1 research peptides.
Product Details
- Peptide: Cagrilintide (CAGRI / AM833)
- Purity: >98% (HPLC verified)
- Form: Lyophilized powder
- Quantity: 5mg per vial
- Storage: Store at -20°C. After reconstitution, refrigerate at 2–8°C and use within 30 days. See how to reconstitute GLP-1 peptides for the step-by-step method.
Research Applications
- Amylin receptor pathway studies
- Appetite and satiety signaling research
- Glucose regulation and post-meal response models
- Energy balance and metabolic function investigations
- Combination research with GLP-1 receptor agonists (e.g., CagriSema)
Why Buy Cagrilintide From MyGLP1Store
Our CAGRI is third-party lab tested with documented purity and comes direct from the manufacturer. MyGLP1Store is a veteran-owned, U.S.-based supplier offering same-day domestic shipping and a verified Trustpilot rating of 4.8 — a trusted source for researchers looking to buy Cagrilintide research peptide in the United States.
Cagrilintide (CAGRI) — Frequently Asked Questions
What is the cagri peptide?
“Cagri” is the research shorthand for Cagrilintide (AM833), a long-acting amylin analog peptide studied in appetite-regulation and metabolic research models. It is supplied here as a 5mg or 10mg lyophilized research vial.
How does cagrilintide differ from tirzepatide in research?
They act on different receptor systems: cagrilintide is an amylin-receptor analog, while tirzepatide is a dual GIP/GLP-1 receptor agonist. In published research they are studied for complementary — not interchangeable — metabolic signaling pathways.
What is CagriSema?
CagriSema is the studied combination of cagrilintide with semaglutide. We supply it as a Cagrilintide + Semaglutide blend for combination-pathway research models.
Is your cagrilintide third-party tested?
Yes — every batch is tested by an independent third-party laboratory for purity and identity before it is released.
Where can I buy cagrilintide?
You can buy cagrilintide directly from MyGLP1Store in 5mg and 10mg research vials with same-day US shipping. For laboratory research use only.
Research References
- Lau DCW, et al. Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled, dose-finding phase 2 trial. Lancet. 2021;398(10317):2160–2170. PubMed
- Enebo LB, et al. Concomitant cagrilintide and semaglutide 2.4 mg for weight management: a randomised, controlled, phase 1b trial. Lancet. 2021;397(10286):1736–1748. PubMed
For laboratory and research use only. Not for human or veterinary consumption. Nothing here is medical advice or a dosing recommendation.
Related Research Compounds
The Cagrilintide peptide is frequently studied alongside other incretin and amylin research compounds. Explore related third-party tested lyophilized peptides:
- Buy Retatrutide (RETA) — triple GIP/GLP-1/glucagon receptor agonist.
- Semaglutide (SEMA) — GLP-1 receptor agonist research peptide.
- Tirzepatide (TIRZ) — dual GIP/GLP-1 agonist.
- Cagrilintide + Semaglutide blend — dual-peptide metabolic research combination.
Cagrilintide — Further Research Reading
Background methodology and comparative data from our research library:
- Semaglutide research guide — the GLP-1 agonist most often paired with cagrilintide in combination models.
- Semaglutide vs tirzepatide — dose comparison across the incretin research class.
- Retatrutide research guide — triple-agonist mechanism and published trial data.
- Quality standards in GLP-1 research — how laboratories evaluate purity and analytical documentation.
- About our research lead — who reviews the analytical data behind every lot.





Reviews
There are no reviews yet.